Profound Medical Corp. (PRN.TO)
9.90
+0.48
(+5.10%)
CAD |
TSX |
Aug 26, 15:56
Profound Medical Debt to Equity Ratio : 0.1482 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1482 |
| March 31, 2026 | 0.1256 |
| December 31, 2025 | 0.0709 |
| September 30, 2025 | 0.148 |
| June 30, 2025 | 0.1226 |
| March 31, 2025 | 0.0961 |
| December 31, 2024 | 0.0848 |
| September 30, 2024 | 0.2005 |
| June 30, 2024 | 0.1695 |
| March 31, 2024 | 0.1578 |
| December 31, 2023 | 0.252 |
| September 30, 2023 | 0.2107 |
| June 30, 2023 | 0.1868 |
| March 31, 2023 | 0.1672 |
| December 31, 2022 | 0.1583 |
| September 30, 2022 | 0.0183 |
| June 30, 2022 | 0.0181 |
| March 31, 2022 | 0.0179 |
| December 31, 2021 | 0.0171 |
| September 30, 2021 | 0.0165 |
| June 30, 2021 | 0.0175 |
| March 31, 2021 | 0.0173 |
| December 31, 2020 | 0.0172 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.0179 |
| June 30, 2020 | 0.0329 |
| March 31, 2020 | 0.0312 |
| December 31, 2019 | 0.7634 |
| September 30, 2019 | 0.6262 |
| June 30, 2019 | 0.7888 |
| March 31, 2019 | 0.6057 |
| December 31, 2018 | 0.449 |
| September 30, 2018 | 0.3791 |
| June 30, 2018 | 0.1055 |
| March 31, 2018 | 0.0935 |
| December 31, 2017 | 0.3707 |
| September 30, 2017 | 0.2982 |
| June 30, 2017 | 0.8059 |
| March 31, 2017 | 0.652 |
| December 31, 2016 | 0.4574 |
| September 30, 2016 | 2.336 |
| June 30, 2016 | 0.955 |
| March 31, 2016 | 0.6104 |
| December 31, 2015 | 0.4473 |
| September 30, 2015 | 0.3597 |
| June 30, 2015 | 0.2971 |
| March 31, 2015 | -0.3918 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| MedMira, Inc. | -0.7106 |
| MedX Health Corp. | -0.8123 |
| VentriPoint Diagnostics Ltd. | -0.632 |
| Theralase Technologies, Inc. | 0.2214 |
| VVT Med, Inc. | -0.4645 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 88.51M |
| Total Liabilities (Quarterly) | 17.84M |
| Shareholders Equity (Quarterly) | 70.67M |
| Current Ratio | 6.459 |
| Net Debt Paydown Yield | -0.20% |